Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Atsuhito Tone"'
Autor:
Akira Okada, Akiko Suganuma, Ken Kato, Atsuhito Tone, Moritsugu Kimura, Satoshi Kawashima, Tomokazu Watanabe, Hideaki Sawaki, Shinsuke Nirengi, Naoki Sakane, Munehide Matsuhisa, Akio Kuroda, Takashi Murata, Masao Toyoda, Yushi Hirota
Publikováno v:
Diabetes Technology & Therapeutics. 22:216-221
Background: Continuous subcutaneous insulin infusion (CSII) is associated with improved glycemic control, a reduced incidence of hypoglycemia, and improved quality of life (QOL). To date, however, ...
Autor:
Shota, Suzuki, Atsuhito, Tone, Takashi, Murata, Kunihiro, Nishimura, Yoshihiro, Miyamoto, Naoki, Sakane, Noriko, Satoh-Asahara, Masao, Toyoda, Yushi, Hirota, Munehide, Matsuhisa, Akio, Kuroda, Ken, Kato, Ryuji, Kouyama, Junnosuke, Miura, Akiko, Suganuma, Tsutomu, Tomita, Michio, Noguchi, Cheol, Son, Masato, Kasahara, Yukie, Ito, Shu, Kasama, Kiminori, Hosoda
Publikováno v:
The Tokai journal of experimental and clinical medicine. 46(2)
Intermittent-scanning continuous glucose monitoring (isCGM) is widely used in type 1 diabetes (T1D) patients; however, the education required to prevent hypoglycemia by using isCGM is not established. This study examines the combined effect of isCGM
Autor:
Moritsugu Kimura, Hideaki Sawaki, Ken Kato, Naoki Sakane, Akira Okada, Satoshi Kawashima, Tomokazu Watanabe, Akiko Suganuma, Atsuhito Tone, Masao Toyoda, Akio Kuroda, Takashi Murata, Shinsuke Nirengi, Yushi Hirota, Munehide Matsuhisa
Publikováno v:
J Diabetes Sci Technol
Background: Information about factors related to better adherence to continuous glucose monitoring (CGM) sensor adherence is quite limited. Materials and Methods: Forty-six participants with type 1 diabetes using continuous subcutaneous insulin infus
Autor:
Miho Tsuruo, Kenji Kamiuchi, Hideaki Sawaki, Akiko Suganuma, Moritsugu Kimura, Masao Toyoda, Naoki Sakane, Satoshi Kawashima, Kensou Osawa, Takashi Murata, Ryuji Kouyama, Ken Kato, Kohshi Narasaki, Atsuhito Tone, Tomokazu Watanabe
Publikováno v:
Internal Medicine
Objective We compared the pain accompanying the injection of high-concentration (300 units/mL) insulin glargine (U300G) with that accompanying the injection of conventional (100 units/mL) insulin glargine (U100G). Methods U100G was switched to U300G